Moolec Science SA (MLEC) - Dilution Analysis

Visualizing historical and potential share dilution over time

Dilution Analysis

Low Risk
Limited dilution potential
Last updated: December 29, 2025

Risk Assessment Details

Potential Dilution: 0.0% of current shares
Recent Dilution: 0% (2 years)
Historical Dilution Factor: minimal recent dilution
Outstanding Shares
11M
Potential Supply
0
Additional shares possible
Splits
None
Past 2 years

Summary

MLEC currently has 10.9M outstanding shares. with minimal authorized share overhang for future dilution. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.

Share Structure Timeline

Outstanding Shares
Total Supply

Historical Data Points

Date Event Outstanding Supply
Dec 29, 2025

20-F filing | 10.9M shares outstanding

11M 0
Jun 17, 2025

POS AM filing: This is a POS AM filing relating to the issuance of shares by the company, shares issuable upon exercise of warrants, and shares offered by selling securityholders.

38M 0
Jun 16, 2025

POS AM filing: This POS AM filing includes the offer and resale of 1,500,000 shares by the company, 11,110,000 shares underlying warrants, and 3,581,828 shares offered by selling securityholders.

38M 0
Nov 25, 2024

POS AM filing: This POS AM filing relates to an offering of up to 5,000,000 ordinary shares by Moolec Science SA under the Nomura Purchase Agreement, potentially generating up to $50 million in gross proceeds for working capital and general corporate purposes. Nomura, acting as the executing broker, has a conflict of interest, but a bona fide public market exists for the shares.

38M 62M
Nov 12, 2024

F-3 filing: The filing relates to the offer and sale of up to 15,000,000 Ordinary Shares by the company, 11,110,000 Ordinary Shares underlying Warrants, and 35,818,285 Ordinary Shares offered by Selling Securityholders.

38M 62M
Oct 30, 2024

20-F filing | 38.4M shares outstanding

38M 0
Nov 15, 2023

POS AM filing: This POS AM filing relates to an offering of Ordinary Shares of Moolec Science SA under the Nomura Purchase Agreement, where up to 5,000,000 shares may be sold to Nomura for up to $50 million in aggregate gross proceeds.

38M 0
Nov 13, 2023

POS AM filing: This POS AM filing registers the issuance of up to 11,110,000 Ordinary Shares upon exercise of warrants at $11.50 per share, and the resale of up to 35,818,285 Ordinary Shares by Selling Securityholders.

38M 5M
Oct 30, 2023

20-F filing | 37.6M shares outstanding

38M 5M
Apr 24, 2023

POS AM filing: This POS AM filing registers the issuance of ordinary shares upon exercise of warrants and the resale of ordinary shares by selling securityholders.

31M 5M
Apr 17, 2023

F-1 filing: This F-1 filing describes an offering of up to 5,000,000 Ordinary Shares by the selling securityholder, Nomura Securities International, Inc., with the issuer potentially receiving up to $50 million in gross proceeds under the Nomura Purchase Agreement.

31M 5M
Mar 31, 2023

POS AM filing: This POS AM filing registers the issuance of up to 11,110,000 Ordinary Shares upon exercise of warrants at $11.50 per share and the resale of up to 35,818,285 Ordinary Shares by Selling Securityholders.

31M 0
Jan 27, 2023

F-1 filing: Registration of Ordinary Shares issuable upon exercise of warrants and resale of Ordinary Shares by Selling Securityholders.

3.6M 47M
Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime